FindTrial
Sign In

Observation and significance of Dexmedetomidine-induced segmental electroencephalogram power spectra

Observation and significance of Dexmedetomidine-induced segmental electroencephalogram power spectra

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021562
Enrollment
Unknown
Registered
2019-02-27
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Nervoussystem

Interventions

Group D:Routine epidural-spinal anesthesia,dexmedetomidine sedation
Group P:Routine epidural-spinal anesthesia,propofol sedation

Sponsors

Sun Yat-sen Memorial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. ASA??; 2. Aged 18-60 years; 3. Male or female; 4. Having sufficient visual and auditory resolution capability to accept testing; 5. Patients undergoing surgery under epidural-spinal anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of cerebrovascular diseases; 2. Patients with secondary metabolic disorders caused by certain endocrine, genetic or neurological disorders. Patients with metabolic diseases induced by drugs; 3. Patients with congenital mental retardation, a family history of dementia, or a diagnosis of dementia, psychosis or other brain dysfunction caused by neuropsychological conditions; 4. Patients with not using any mediations; 5. Patients with any malignant diseases.

Design outcomes

Primary

MeasureTime frame
segmental electroencephalogram power spectra;—

Secondary

MeasureTime frame
blood pressure;heart rate;oxygen saturation;—

Countries

China

Contacts

Public ContactPeng Shuling

Anesthesiology Department, Sun Yat-sen Memorial Hospital

pslmzk@aliyun.com+86 13662313366

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026